Skip to content

Author

C. B. Westphalen

We have 2 of 27 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Abstract IA012: A New Perspective: Clinical Trials in the Era of RAS Inhibitors

The demonstration of an overall survival benefit for RAS(ON) multi-selective inhibition in previously treated metastatic pancreatic ductal adenocarcinoma (RASolute 302) establishes the first randomised evidence for RAS-directed therapy in this disease. Previously, biomarker-directed treatment in PDAC reached a minori...

C. B. Westphalen · 0 citations
Review Open access Sep 2026

Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission.

The Commission developed a value-based resource-stratified implementation framework, a system-readiness assessment tool, a precision oncology workforce competency-based framework, a precision oncology monitoring and evaluation framework, and principles for responsible data sharing and health-system learning.

R. Casolino, J. Mateo, E. D. de Vries et al. · 11 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.